Innate sensing of malaria parasites

Innate immune receptors have a key role in immune surveillance by sensing microorganisms and initiating protective immune responses. However, the innate immune system is a classic 'double-edged sword' that can overreact to pathogens, which can have deleterious effects and lead to clinical manifestations. Recent studies have unveiled the complexity of innate immune receptors that function as sensors of Plasmodium spp. in the vertebrate host. This Review highlights the cellular and molecular mechanisms by which Plasmodium infection is sensed by different families of innate immune receptors. We also discuss how these events mediate both host resistance to infection and the pathogenesis of malaria.

[1]  D. Kwiatkowski,et al.  Anti-TNF therapy inhibits fever in cerebral malaria. , 1993, The Quarterly journal of medicine.

[2]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[3]  B. Lowe,et al.  Bacteraemia complicating severe malaria in children. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[5]  J. Frangos,et al.  Nitric Oxide Synthase Dysfunction Contributes to Impaired Cerebroarteriolar Reactivity in Experimental Cerebral Malaria , 2013, PLoS pathogens.

[6]  Evelin Schwarzer,et al.  Malarial pigment haemozoin, IFN-gamma, TNF-alpha, IL-1beta and LPS do not stimulate expression of inducible nitric oxide synthase and production of nitric oxide in immuno-purified human monocytes , 2007, Malaria Journal.

[7]  A. Coutinho,et al.  IFNAR1 Controls Progression to Cerebral Malaria in Children and CD8+ T Cell Brain Pathology in Plasmodium berghei–Infected Mice , 2013, The Journal of Immunology.

[8]  R. Panatieri,et al.  IFN-γ–Induced Priming Maintains Long-Term Strain-Transcending Immunity against Blood-Stage Plasmodium chabaudi Malaria , 2013, The Journal of Immunology.

[9]  L. Rénia,et al.  Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. , 2009, Blood.

[10]  N. Câmara,et al.  MyD88 Signaling Is Directly Involved in the Development of Murine Placental Malaria , 2013, Infection and Immunity.

[11]  O. Doumbo,et al.  Evidence That Interferon-γ Plays a Protective Role during Cerebral Malaria , 2005 .

[12]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[13]  M. Mota,et al.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.

[14]  Kevin Marsh,et al.  Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. , 2013, The New England journal of medicine.

[15]  D. Golenbock,et al.  MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. , 2007, Microbes and infection.

[16]  F. Hackett,et al.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites , 1993, The Journal of experimental medicine.

[17]  D. Golenbock,et al.  UNC93B1 and Nucleic Acid-sensing Toll-like Receptors Mediate Host Resistance to Infection with Leishmania major* , 2013, The Journal of Biological Chemistry.

[18]  C. Ince,et al.  Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. , 2008, The Journal of infectious diseases.

[19]  P. Arese,et al.  Involvement of Inflammatory Chemokines in Survival of Human Monocytes Fed with Malarial Pigment , 2010, Infection and Immunity.

[20]  L. F. Fajardo,et al.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.

[21]  R. Coffman,et al.  Development of TLR inhibitors for the treatment of autoimmune diseases , 2008, Immunological reviews.

[22]  S. Luckhart,et al.  Malaria Parasite Infection Compromises Control of Concurrent Systemic Non-typhoidal Salmonella Infection via IL-10-Mediated Alteration of Myeloid Cell Function , 2014, PLoS pathogens.

[23]  J. Crump,et al.  Invasive non-Typhi Salmonella disease in Africa. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Charles C. Kim,et al.  Toll-Like Receptor 7 Mediates Early Innate Immune Responses to Malaria , 2013, Infection and Immunity.

[25]  D. Golenbock,et al.  Dual engagement of the NLRP3 and AIM2 inflammasomes by plasmodium-derived hemozoin and DNA during malaria. , 2014, Cell reports.

[26]  P. E. Van den Steen,et al.  Pathogenesis of malaria-associated acute respiratory distress syndrome. , 2013, Trends in parasitology.

[27]  D. Golenbock,et al.  Malaria-Induced NLRP12/NLRP3-Dependent Caspase-1 Activation Mediates Inflammation and Hypersensitivity to Bacterial Superinfection , 2014, PLoS pathogens.

[28]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[29]  V. A. Stewart,et al.  Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. , 2009, The Journal of infectious diseases.

[30]  Trees Jansen,et al.  Plasmodium falciparum Infection Causes Proinflammatory Priming of Human TLR Responses1 , 2007, The Journal of Immunology.

[31]  A. Haque,et al.  Type I interferons suppress CD4+ T‐cell‐dependent parasite control during blood‐stage Plasmodium infection , 2011, European journal of immunology.

[32]  J. Stockman.  A Field Trial to Assess a Blood-Stage Malaria Vaccine , 2013 .

[33]  M. Segura,et al.  Interaction of Mouse Dendritic Cells and Malaria-Infected Erythrocytes: Uptake, Maturation, and Antigen Presentation1 , 2006, The Journal of Immunology.

[34]  M. Grisotto,et al.  Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[35]  P. Seeberger,et al.  MyD88/IL-18-dependent pathways rather than TLRs control early parasitaemia in non-lethal Plasmodium yoelii infection. , 2008, Microbes and infection.

[36]  J. Oppenheim,et al.  Biochemical characterization of Plasmodium falciparum hemozoin. , 1990, The American journal of tropical medicine and hygiene.

[37]  M. Molyneux,et al.  Plasmodium falciparum‐ infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes , 2007, Journal of thrombosis and haemostasis : JTH.

[38]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[39]  B. Greenwood,et al.  Plasmodium falciparum malaria and Salmonella infections in Gambian children. , 1987, The Journal of infectious diseases.

[40]  Nancy Fullman,et al.  Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.

[41]  I. Charles,et al.  Inducible nitric oxide synthase polymorphism and fatal cerebral malaria , 1998, The Lancet.

[42]  E. Riley,et al.  Innate immunity to malaria , 2004, Nature Reviews Immunology.

[43]  F. Ginhoux,et al.  Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection , 2013, Nature Medicine.

[44]  Thomas A. Smith,et al.  A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. , 2002, The Journal of infectious diseases.

[45]  P. Gerold,et al.  Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. , 1996, Journal of immunology.

[46]  M. Smyth,et al.  Plasmodium Strain Determines Dendritic Cell Function Essential for Survival from Malaria , 2007, PLoS pathogens.

[47]  M. Stevenson,et al.  Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. , 2004, International journal for parasitology.

[48]  R. Swaminathan,et al.  Overview of Circulating Nucleic Acids in Plasma/Serum , 2008, Annals of the New York Academy of Sciences.

[49]  Ana Rodriguez,et al.  A Surprising Role for Uric Acid: The Inflammatory Malaria Response , 2014, Current Rheumatology Reports.

[50]  G. Superti-Furga,et al.  Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection , 2013, Nature Medicine.

[51]  N. Day,et al.  Lethal Malaria: Marchiafava and Bignami Were Right , 2013, The Journal of infectious diseases.

[52]  Mario Roederer,et al.  Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.

[53]  M. Stevenson,et al.  IL-12 Is Required for Antibody-Mediated Protective Immunity Against Blood-Stage Plasmodium chabaudi AS Malaria Infection in Mice1 , 2002, The Journal of Immunology.

[54]  Ana Rodriguez,et al.  Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome , 2010, European journal of immunology.

[55]  A. Sher,et al.  IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. , 1995, Journal of immunology.

[56]  G. Grau,et al.  Platelets Potentiate Brain Endothelial Alterations Induced by Plasmodium falciparum , 2006, Infection and Immunity.

[57]  R. Price,et al.  Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. , 2012, Advances in parasitology.

[58]  P. Seeberger,et al.  Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria , 2002, Nature.

[59]  J. Hittner,et al.  Bacteremia in Kenyan Children Presenting with Malaria , 2010, Journal of Clinical Microbiology.

[60]  B. Ryffel,et al.  Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood‐stage Plasmodium berghei ANKA , 2013, European journal of immunology.

[61]  Pardis C Sabeti,et al.  CD40L association with protection from severe malaria , 2002, Genes and Immunity.

[62]  A. Vaughan,et al.  Interferon-mediated innate immune responses against malaria parasite liver stages. , 2014, Cell reports.

[63]  P. Piazza,et al.  Mechanisms of erythropoiesis inhibition by malarial pigment and malaria‐induced proinflammatory mediators in an in vitro model , 2011, American journal of hematology.

[64]  E. Denkers,et al.  Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism , 2006, Nature Reviews Immunology.

[65]  P. Vassalli,et al.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. T. McIntosh,et al.  Pure Hemozoin Is Inflammatory In Vivo and Activates the NALP3 Inflammasome via Release of Uric Acid1 , 2009, The Journal of Immunology.

[67]  P. Gerold,et al.  Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. , 1996, Journal of immunology.

[68]  W. Wernsdorfer,et al.  Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. , 1998, The American journal of tropical medicine and hygiene.

[69]  A. Avery,et al.  Cutting Edge: The Acquisition of TLR Tolerance during Malaria Infection Impacts T Cell Activation 1 , 2005, The Journal of Immunology.

[70]  M. Hutz,et al.  IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil , 2012, Malaria Journal.

[71]  A. Teixeira-Carvalho,et al.  Augmented plasma microparticles during acute Plasmodium vivax infection , 2010, Malaria Journal.

[72]  Kevin Marsh,et al.  Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study , 2011, The Lancet.

[73]  N. White,et al.  Respiratory manifestations of malaria. , 2012, Chest.

[74]  M. Toner,et al.  Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. , 2013, Cell host & microbe.

[75]  S. Hoffman,et al.  Interleukin 12 induction of interferon gamma-dependent protection against malaria. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Lisanti,et al.  Cerebral malaria: we have come a long way. , 2012, The American journal of pathology.

[77]  D. Golenbock,et al.  The CD14+CD16+ Inflammatory Monocyte Subset Displays Increased Mitochondrial Activity and Effector Function During Acute Plasmodium vivax Malaria , 2014, PLoS pathogens.

[78]  E. Riley,et al.  Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization , 2011, Nature Medicine.

[79]  I. C. Almeida,et al.  Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses , 2001, Journal of leukocyte biology.

[80]  C. Newton,et al.  Pathogenesis, clinical features, and neurological outcome of cerebral malaria , 2005, The Lancet Neurology.

[81]  E. Riley,et al.  Innate Immune Response to Malaria: Rapid Induction of IFN-γ from Human NK Cells by Live Plasmodium falciparum-Infected Erythrocytes1 , 2002, The Journal of Immunology.

[82]  J. Tschopp,et al.  Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal , 2009, PloS one.

[83]  Sangdun Choi,et al.  Structure and dynamic behavior of Toll‐like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum , 2013, The FEBS journal.

[84]  R. Schumann,et al.  Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. , 2006, The Journal of infectious diseases.

[85]  K. Matuschewski,et al.  Caspase-1 Activation of Interleukin-1β (IL-1β) and IL-18 Is Dispensable for Induction of Experimental Cerebral Malaria , 2011, Infection and Immunity.

[86]  S. Ghosh,et al.  Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. , 2013, Cell host & microbe.

[87]  D. Boakye,et al.  Enhanced Toll-Like Receptor Responsiveness Associated with Mitogen-Activated Protein Kinase Activation in Plasmodium falciparum-Infected Children , 2008, Infection and Immunity.

[88]  L. Rénia,et al.  Recombinant Human IFN-α Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice1 , 2007, The Journal of Immunology.

[89]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[90]  E. Kenangalem,et al.  Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria , 2013, The Journal of experimental medicine.

[91]  David L. Smith,et al.  A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 , 2012, PLoS neglected tropical diseases.

[92]  L. H. Carvalho,et al.  Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria , 2011, PloS one.

[93]  E. Riley,et al.  Prolonged Neutrophil Dysfunction after Plasmodium falciparum Malaria Is Related to Hemolysis and Heme Oxygenase-1 Induction , 2012, The Journal of Immunology.

[94]  R. Price,et al.  Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality. , 2013, The Journal of infectious diseases.

[95]  C. Coban,et al.  Immunogenicity of Whole-parasite Vaccines against Plasmodium Falciparum Involves Malarial Hemozoin and Host Tlr9 , 2022 .

[96]  T. Myers,et al.  Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality , 2014, Proceedings of the National Academy of Sciences.

[97]  E. Riley,et al.  Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes. , 2013, Trends in parasitology.

[98]  N. White,et al.  The activation of vivax malaria hypnozoites by infectious diseases. , 2013, The Lancet. Infectious diseases.

[99]  Carl G. Figdor,et al.  Different Faces of the Heme-Heme Oxygenase System in Inflammation , 2003, Pharmacological Reviews.

[100]  L. Rénia,et al.  Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity. , 2014, The Journal of clinical investigation.

[101]  Fernando Ontiveros,et al.  The sterile inflammatory response. , 2010, Annual review of immunology.

[102]  O. Skorokhod,et al.  Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. , 2011, Blood.

[103]  C. Coban,et al.  Pathological role of Toll-like receptor signaling in cerebral malaria. , 2006, International immunology.

[104]  M. Boivin,et al.  TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. , 2010, The American journal of tropical medicine and hygiene.

[105]  A. Tager,et al.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria , 2008, Proceedings of the National Academy of Sciences.

[106]  V. Prendki,et al.  The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. , 2011, Blood.

[107]  M. Molyneux,et al.  Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. , 2007, The Journal of infectious diseases.

[108]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[109]  R. Figueiredo,et al.  Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.

[110]  L. Hviid,et al.  Malaria in pregnancy: pathogenesis and immunity. , 2007, The Lancet. Infectious diseases.

[111]  M. Good,et al.  What really happens to dendritic cells during malaria? , 2008, Nature Reviews Microbiology.

[112]  A. Tardivel,et al.  Sporozoite-Mediated Hepatocyte Wounding Limits Plasmodium Parasite Development via MyD88-Mediated NF-κB Activation and Inducible NO Synthase Expression1 , 2008, The Journal of Immunology.

[113]  D. Kwiatkowski,et al.  Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia , 2003, Genes and Immunity.

[114]  D. Golenbock,et al.  Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. , 2011, Immunity.

[115]  L. Schofield,et al.  Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.

[116]  S. Akira,et al.  Induction of Proinflammatory Responses in Macrophages by the Glycosylphosphatidylinositols of Plasmodium falciparum , 2005, Journal of Biological Chemistry.

[117]  C. Chitnis,et al.  Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection , 2008, Proceedings of the National Academy of Sciences.

[118]  Nathan D. Wolfe,et al.  Common and Divergent Immune Response Signaling Pathways Discovered in Peripheral Blood Mononuclear Cell Gene Expression Patterns in Presymptomatic and Clinically Apparent Malaria , 2006, Infection and Immunity.

[119]  K. Duca,et al.  A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis , 2014, PLoS pathogens.

[120]  P. Mantel,et al.  The role of extracellular vesicles in Plasmodium and other protozoan parasites , 2014, Cellular microbiology.

[121]  D. Kwiatkowski,et al.  IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. , 2002, The Journal of infectious diseases.

[122]  Xianzhu Wu,et al.  TLR9 and MyD88 Are Crucial for the Development of Protective Immunity to Malaria , 2012, The Journal of Immunology.

[123]  N. Anstey,et al.  Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression , 1996, The Journal of experimental medicine.

[124]  D. Ferguson,et al.  Intraleucocytic malaria pigment and prognosis in severe malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[125]  R. Bucala,et al.  Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. , 2007, The Journal of infectious diseases.

[126]  D. J. Perkins,et al.  Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults , 2010, Immunogenetics.

[127]  Joseph D. Smith,et al.  A family affair: var genes, PfEMP1 binding, and malaria disease. , 2006, Current opinion in microbiology.

[128]  Adrian J F Luty,et al.  Protection against a malaria challenge by sporozoite inoculation. , 2009, The New England journal of medicine.

[129]  C. Coban,et al.  Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets. , 2014, Vaccine.

[130]  D. L. van de Hoef,et al.  Plasma Uric Acid Levels Correlate with Inflammation and Disease Severity in Malian Children with Plasmodium falciparum Malaria , 2012, PloS one.

[131]  I. Bechmann,et al.  Sickle Hemoglobin Confers Tolerance to Plasmodium Infection , 2011, Cell.

[132]  L. Rivière,et al.  Antigenic variation in Plasmodium falciparum. , 2008, Annual review of microbiology.

[133]  Ana Rodriguez,et al.  Plasmodium-Induced Inflammation by Uric Acid , 2008, PLoS pathogens.

[134]  C. Coban,et al.  Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.

[135]  J. Andersen,et al.  HDP—A Novel Heme Detoxification Protein from the Malaria Parasite , 2008, PLoS pathogens.

[136]  R. Sinden,et al.  Innate Immune Responses to Human Malaria: Heterogeneous Cytokine Responses to Blood-Stage Plasmodium falciparum Correlate with Parasitological and Clinical Outcomes1 , 2006, The Journal of Immunology.

[137]  H. D. del Portillo,et al.  The role of the spleen in malaria , 2012, Cellular microbiology.

[138]  Sarah E. Ewald,et al.  Nucleic acid recognition by the innate immune system. , 2011, Annual review of immunology.

[139]  I. Clark,et al.  Human malarial disease: a consequence of inflammatory cytokine release , 2006, Malaria Journal.

[140]  D. Golenbock,et al.  Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function , 2009, Proceedings of the National Academy of Sciences.

[141]  D. Golenbock,et al.  Neutrophil Paralysis in Plasmodium vivax Malaria , 2012, PLoS neglected tropical diseases.

[142]  B. Ryffel,et al.  Parasite-Derived Plasma Microparticles Contribute Significantly to Malaria Infection-Induced Inflammation through Potent Macrophage Stimulation , 2010, PLoS pathogens.

[143]  F. Sutterwala,et al.  Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases , 2009, PLoS pathogens.

[144]  R. Schumann,et al.  Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. , 2006, The Journal of communicable diseases.

[145]  B. Monks,et al.  Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.

[146]  J. Stockman.  First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children , 2013 .

[147]  P. Arese,et al.  Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes , 1998, Infection and Immunity.

[148]  A. Pain,et al.  Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells , 1999, Nature.

[149]  Sanjeev Kumar,et al.  Protein–DNA Complex Is the Exclusive Malaria Parasite Component That Activates Dendritic Cells and Triggers Innate Immune Responses , 2010, The Journal of Immunology.

[150]  X. Su,et al.  Malaria biology and disease pathogenesis: insights for new treatments , 2013, Nature Medicine.

[151]  安達 圭志.  Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism , 2003 .

[152]  V. A. Stewart,et al.  Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway1 , 2004, The Journal of Immunology.

[153]  L. Kühn,et al.  Metabolic adaptation to tissue iron overload confers tolerance to malaria. , 2012, Cell host & microbe.

[154]  J. Kalil,et al.  Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. , 2008, The Journal of infectious diseases.

[155]  Jean Gosselin,et al.  Synthetic Plasmodium-Like Hemozoin Activates the Immune Response: A Morphology - Function Study , 2009, PloS one.

[156]  Douglas T. Golenbock,et al.  Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria , 2011, Proceedings of the National Academy of Sciences.

[157]  M. Molyneux,et al.  Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. , 2004, JAMA.

[158]  H. D. del Portillo,et al.  Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential. , 2014, The Journal of infectious diseases.

[159]  V. A. Stewart,et al.  Immune mechanisms in malaria: new insights in vaccine development , 2013, Nature Medicine.

[160]  Douglas Golenbock,et al.  The history of Toll-like receptors — redefining innate immunity , 2013, Nature Reviews Immunology.

[161]  K. Tracey,et al.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.

[162]  R. Good,et al.  Transcriptional profiling reveals suppressed erythropoiesis, up-regulated glycolysis, and interferon-associated responses in murine malaria. , 2004, The Journal of infectious diseases.